These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 14688813
1. Endothelial dysfunction in patients with white coat hypertension. Coban E, Timurağaoğlu A, Ozdoğan M. J Hum Hypertens; 2004 Jan; 18(1):71-2. PubMed ID: 14688813 [No Abstract] [Full Text] [Related]
2. Endothelium and angiogenesis in white coat hypertension. Karter Y, Aydin S, Curgunlu A, Uzun H, Ertürk N, Vehid S, Kutlu A, Simsek G, Yücel R, Arat A, Ozturk E, Erdine S. J Hum Hypertens; 2004 Nov; 18(11):809-14. PubMed ID: 15215878 [Abstract] [Full Text] [Related]
3. C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives. Conen D, Dieterle T, Utech K, Rimner M, Martina B. Hypertens Res; 2006 Jun; 29(6):411-5. PubMed ID: 16940703 [Abstract] [Full Text] [Related]
4. Endothelial function in sustained and white coat hypertension. Pierdomenico SD, Cipollone F, Lapenna D, Bucci A, Cuccurullo F, Mezzetti A. Am J Hypertens; 2002 Nov; 15(11):946-52. PubMed ID: 12441213 [Abstract] [Full Text] [Related]
5. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. Varughese GI, Patel JV, Tomson J, Blann AD, Hughes EA, Lip GY. J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113 [Abstract] [Full Text] [Related]
6. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care]. Villalba Alcalá F, Lapetra Peralta J, Mayoral Sánchez E, Espino Montoro A, Cayuela Domínguez A, López Chozas JM. Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850 [Abstract] [Full Text] [Related]
7. Higher blood pressure load (baric impact) in normotensives with endothelial dysfunction: a paraphysiological status of "pre-hypertension". Cugini P, Baldoni F, De Rosa R, Pandolfi C, Colotto M, Buccarella PA, Zamparelli C, Berti D, Passini B, Roncoroni V, Sabino D, Capria A. Clin Ter; 2002 Jul; 153(5):309-15. PubMed ID: 12510414 [Abstract] [Full Text] [Related]
8. The mean platelet volume in patients with essential and white coat hypertension. Coban E, Yazicioglu G, Berkant Avci A, Akcit F. Platelets; 2005 Nov; 16(7):435-8. PubMed ID: 16236605 [Abstract] [Full Text] [Related]
17. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. Lee KW, Blann AD, Lip GY. Int J Cardiol; 2006 Aug 10; 111(2):302-8. PubMed ID: 16324758 [Abstract] [Full Text] [Related]
18. Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure. Larkin KT, Schauss SL, Elnicki DM, Goodie JL. J Hum Hypertens; 2007 Jul 10; 21(7):516-24. PubMed ID: 17361194 [Abstract] [Full Text] [Related]